Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-009998

CHIEF OPERATING OFFICER gave up 1,034 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 3,519 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Option exercise +1,773 79,726 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Option exercise +1,746 81,472 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Shares withheld for taxes −521 $21.77 $11,342 80,951 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Shares withheld for taxes −513 $21.77 $11,168 80,438 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Grant or award · Share Option +39,364 39,364 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Grant or award · Restricted Share Unit +9,828 9,828 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Grant or award · Performance Share Unit +19,657 19,657 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Option exercise · Restricted Share Unit −1,773 3,545 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-01 Option exercise · Restricted Share Unit −1,746 5,235 D
Loading xslF345X05/form4-04032025_090432.xml…